Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP578354.RAPCWfVCkMX3cm5fcnq5PA9aRfDFRBzU2UEulTUCnHpvQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP578354.RAPCWfVCkMX3cm5fcnq5PA9aRfDFRBzU2UEulTUCnHpvQ130_assertion type Assertion NP578354.RAPCWfVCkMX3cm5fcnq5PA9aRfDFRBzU2UEulTUCnHpvQ130_head.
- NP578354.RAPCWfVCkMX3cm5fcnq5PA9aRfDFRBzU2UEulTUCnHpvQ130_assertion description "[The cancer antigen CA 15-3 has been used as a possible serum marker of occult and recurrent breast carcinoma, either alone or in combination with other tumor markers such as HER2/neu, that has evolved as a major classifier of invasive breast cancer and target of therapy for the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP578354.RAPCWfVCkMX3cm5fcnq5PA9aRfDFRBzU2UEulTUCnHpvQ130_provenance.
- NP578354.RAPCWfVCkMX3cm5fcnq5PA9aRfDFRBzU2UEulTUCnHpvQ130_assertion evidence source_evidence_literature NP578354.RAPCWfVCkMX3cm5fcnq5PA9aRfDFRBzU2UEulTUCnHpvQ130_provenance.
- NP578354.RAPCWfVCkMX3cm5fcnq5PA9aRfDFRBzU2UEulTUCnHpvQ130_assertion SIO_000772 24674678 NP578354.RAPCWfVCkMX3cm5fcnq5PA9aRfDFRBzU2UEulTUCnHpvQ130_provenance.
- NP578354.RAPCWfVCkMX3cm5fcnq5PA9aRfDFRBzU2UEulTUCnHpvQ130_assertion wasDerivedFrom befree-20150227 NP578354.RAPCWfVCkMX3cm5fcnq5PA9aRfDFRBzU2UEulTUCnHpvQ130_provenance.
- NP578354.RAPCWfVCkMX3cm5fcnq5PA9aRfDFRBzU2UEulTUCnHpvQ130_assertion wasGeneratedBy ECO_0000203 NP578354.RAPCWfVCkMX3cm5fcnq5PA9aRfDFRBzU2UEulTUCnHpvQ130_provenance.